stats
globeinteractive.com: Making the Business of Life Easier

   Finance globeinvestor   Careers globecareers.workopolis Subscribe to The Globe
The Globe and Mail /globeandmail.com
Home | Business | National | Int'l | Sports | Columnists | The Arts | Tech | Travel | TV | Wheels
space


Search

space
  This site         Tips

  
space
  The Web Google
space
   space



space

  Where to Find It


Breaking News
  Home Page

  Report on Business

  Sports

  Technology

space
Subscribe to The Globe

Shop at our Globe Store


Print Edition
  Front Page

  Report on Business

  National

  International

  Sports

  Arts & Entertainment

  Editorials

  Columnists

   Headline Index

 Other Sections
  Appointments

  Births & Deaths

  Books

  Classifieds

  Comment

  Education

  Environment

  Facts & Arguments

  Focus

  Health

  Obituaries

  Real Estate

  Review

  Science

  Style

  Technology

  Travel

  Wheels

 Leisure
  Cartoon

  Crosswords

  Food & Dining

  Golf

  Horoscopes

  Movies

  Online Personals

  TV Listings/News

 Specials & Series
  All Reports...

space

Services
   Where to Find It
 A quick guide to what's available on the site

 Newspaper
  Advertise

  Corrections

  Customer Service

  Help & Contact Us

  Reprints

  Subscriptions

 Web Site
  Advertise

  E-Mail Newsletters

  Free Headlines

  Globe Store New

  Help & Contact Us

  Make Us Home

  Mobile New

  Press Room

  Privacy Policy

  Terms & Conditions


GiveLife.ca

    

PRINT EDITION
Altria buys stake in cannabis producer Cronos for $2.4-billion
space
space
By CHRISTINA PELLEGRINI
  
  

Email this article Print this article
Saturday, December 8, 2018 – Page B1

Big tobacco, meet Canadian cannabis.

Altria Group Inc., the maker of Marlboro cigarettes, has struck a deal to buy a large stake in Cronos Group Inc., a cannabis grower in Toronto.

Richmond, Va.-based Altria said Friday in a media release that it agreed to pay $2.4-billion to acquire a 45-per-cent stake in Cronos. The agreement also includes a warrant that, if exercised, could see Altria's ownership rise to 55 per cent for another $1.4-billion.

The first Canadian cannabis grower to list its shares on a U.S. stock market, Cronos said it plans to spend the money on product innovation, noting Altria's expertise in device technology and automation, and fuel Cronos's expansion into new countries amid a global shift toward loosening restrictions on the drug.

"This is a huge validation of the industry and our model," Mike Gorenstein, chief executive at Cronos, said by phone. "This is just another stamp of approval that there is a huge opportunity in cannabis and that it is a legitimate industry."

The deal marks the entry of another consumergoods giant into Canada's legal cannabis industry.

Constellation Brands Inc., maker of alcoholic beverages, has invested more than $5-billion for control of Canopy Growth Corp., while Molson Coors Brewing Co. is looking to create cannabis-infused beverages through a joint venture with Quebec's Hexo Corp.

Altria's entry could also help restore confidence in Canada's nascent cannabis sector. Canadian pot stocks have been crushed in recent weeks after a lacklustre start to recreational sales amid reports of countrywide supply shortages. This week, Aphria Inc., one of the country's largest cannabis growers, was defending itself against accusations of striking deals to enrich insiders made in a widely read shortsellers' report. Investors, meanwhile, have been pouring money into cannabis companies that operate in multiple U.S. states, pivoting away from Canada.

Cronos's stock closed 22 per cent higher at $17.06 in Toronto, while shares of Altria fell 0.4 per cent.

"We believe an investment of this magnitude provides overall legitimacy to the industry as a whole and should represent a positive catalyst for the sector, with the news likely to drive valuations higher," said Canaccord Genuity analyst Matt Bottomley, who has a 12-month price target of $9 on Cronos's stock and a "hold" rating.

Altria had been in talks with cannabis companies for months, as its core cigarette business continues to shrink.

It also weighed making investments in other growers, such as Aphria and CannTrust Holdings Inc., according to sources familiar with the matter who were granted anonymity because the talks were private. Altria declined an interview request and didn't speak on a conference call on Friday held by Cronos.

In a separate news release on Friday, Altria said it is discontinuing its existing e-cigarette brands and will take a US$200million charge on these assets in its next quarter.

It said it was doing so because it doesn't "see a path to leadership with these particular products," as well as the regulatory burden it faces to bring them to market. Altria is in talks to acquire a stake in e-cigarette startup Juul Labs Inc., according to reports by U.S. media outlets.

Cronos, meanwhile, grows and sells medical and recreational cannabis in Canada, operating two growing facilities in Ontario and one in British Columbia. It has entered into joint ventures to boost its presence and capacity in Canada and abroad, including in Israel and Australia.

But Cronos is not among Canada's largest cannabis producers - it generated just $3.8-million in revenue in its most recent quarter.

Cronos plans to focus on cannabis genetics, innovation and branding, while contracting with farmers to grow the product and working with retailers. Altria shares that vision, Mr.

Gorenstein said.

Cronos has partnered with Boston biotech firm Ginkgo Bioworks Inc. to genetically engineer the active compounds of cannabis.

"A lot of people talk about how important capacity is and growing in cannabis," Mr. Gorenstein added Friday on the conference call. "I think it's worth noting that Altria doesn't grow their own tobacco. We think that that model of growing your own plants is very difficult to scale and execute well."

Altria will nominate four directors to Cronos's board, which will increase to seven directors from five. The deal is expected to close in the first half of 2019.

JPMorgan Chase Bank NA, a subsidiary of JPMorgan Chase & Co., is providing financing to Altria.

Bank of America Merrill Lynch financed Constellation's deal with Canopy. There weren't any Canadian-headquartered advisers involved in either deal. Canada's top lenders, who have largely refused to serve clients in the cannabis sector for years, are now getting shut out of the sector's biggest transactions.

Cronos confirmed last Friday that it was in talks with Altria after a Reuters report.

Short-seller Andrew Left of Citron Research, who has been a critic of Cronos and was betting against the stock going into Friday, said that this deal shows why Canadian growers trade at a premium to U.S.-based cannabis companies.

"I think it shows that the U.S.

players - Altria and Constellation - will not buy into a U.S.

cannabis company until it becomes federally legal in the U.S.," said Mr. Left, making the big Canadian producers "more valuable for that reason. This puts a bid under the market for the next year."

CRONOS GROUP (CRON) CLOSE: US$12.72, UP 2.27 US CENTS

Associated Graphic

A cannabis plant approaches maturity at a licensed growing facility in Fenwick, Ont. Cronos plans to use its cash infusion from Altria to focus on genetics, innovation and branding. TIJANA MARTIN/THE CANADIAN PRESS


Huh? How did I get here?
Return to Main David_Macfarlane Page
Subscribe to
The Globe and Mail
 

Email this article Print this article

space  Advertisement
space

Need CPR for your RSP? Check your portfolio’s pulse and lower yours by improving the overall health of your investments. Click here.

Advertisement

7-Day Site Search
    

Breaking News



Today's Weather


Inside

Rick Salutin
Merrily marching
off to war
Roy MacGregor
Duct tape might hold
when panic strikes


Editorial
Where Manley is going with his first budget




space

Columnists



For a columnist's most recent stories, click on their name below.

 National


Roy MacGregor arrow
This Country
space
Jeffrey Simpson arrow
The Nation
space
Margaret Wente arrow
Counterpoint
space
Hugh Winsor  arrow
The Power Game
space
 Business


Rob Carrick arrow
Personal Finance
space
Drew Fagan arrow
The Big Picture
space
Mathew Ingram arrow
space
Brent Jang arrow
Business West
space
Brian Milner arrow
Taking Stock
space
Eric Reguly arrow
To The Point
space
Andrew Willis arrow
Streetwise
space
 Sports


Stephen Brunt arrow
The Game
space
Eric Duhatschek arrow
space
Allan Maki arrow
space
William Houston arrow
Truth & Rumours
space
Lorne Rubenstein arrow
Golf
space
 The Arts


John Doyle arrow
Television
space
John MacLachlan Gray arrow
Gray's Anatomy
space
David Macfarlane arrow
Cheap Seats
space
Johanna Schneller arrow
Moviegoer
space
 Comment


Murray Campbell arrow
Ontario Politics
space
Lysiane Gagnon arrow
Inside Quebec
space
Marcus Gee arrow
The World
space
William Johnson arrow
Pit Bill
space
Paul Knox arrow
Worldbeat
space
Heather Mallick arrow
As If
space
Leah McLaren arrow
Generation Why
space
Rex Murphy arrow
Japes of Wrath
space
Rick Salutin arrow
On The Other Hand
space
Paul Sullivan arrow
The West
space
William Thorsell arrow
space





Home | Business | National | Int'l | Sports | Columnists | The Arts | Tech | Travel | TV | Wheels
space

© 2003 Bell Globemedia Interactive Inc. All Rights Reserved.
Help & Contact Us | Back to the top of this page